Contraception News and Research

RSS
New family planning app found to be as effective as modern methods

New family planning app found to be as effective as modern methods

New 'gag rule' may adversely impact health care of pregnant women

New 'gag rule' may adversely impact health care of pregnant women

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

‘Contraception deserts’ likely to widen under new Trump administration policy

‘Contraception deserts’ likely to widen under new Trump administration policy

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Ovarian cancer risk reduced among women taking modern combined oral contraceptive pills

Ovarian cancer risk reduced among women taking modern combined oral contraceptive pills

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Must-reads of the week from Brianna Labuskes

Must-reads of the week from Brianna Labuskes

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Podcast: KHN’s ‘What the Health?’ Health policy goes to court

Podcast: KHN’s ‘What the Health?’ Health policy goes to court

Medicaid expansion may fill gap in reproductive health care access, study finds

Medicaid expansion may fill gap in reproductive health care access, study finds

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

Pregnant women with heart disease must give birth at 40 weeks gestation

Pregnant women with heart disease must give birth at 40 weeks gestation

Biorhythms and birth control: FDA stirs debate by approving ‘natural’ app

Biorhythms and birth control: FDA stirs debate by approving ‘natural’ app

Digital birth control app gets FDA nod

Digital birth control app gets FDA nod

Study finds increased rate of repeat pregnancies in women with intellectual and developmental disabilities

Study finds increased rate of repeat pregnancies in women with intellectual and developmental disabilities